Geometry Dash APK Hill Climb Racing APK
74.8 F
New York
Sunday, August 14, 2022

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Stock Moves out of The Trading Zone on Wednesday

Must read

Is Tilray Inc (NASDAQ:TLRY) Stock a Good Buy After The Recent Fall?

The cannabis sector may have had a hard time not too long ago but over the course of the past months, the...

Sysorex Inc (OTCMKTS:SYSX) Stock Still Riding Big News

Investors are always drawn to stocks that make a big jump out of nowhere. So it's no surprise that Sysorex Inc (OTCMKTS:SYSX)...

88 Energy Limited Ltd (EEENF) Update: Continues Climbing on Significant Volume

Investors who might be looking for stocks that have made considerable gains in recent weeks could consider having a closer look at...

Victory Resources Corporation (OTCMKTS:VRCFF) Stock Rockets After Announcing A New Acquisition

Nowadays, lithium is in huge demand across several industries and hence, it the rally in the Victory Resources Corporation (OTCMKTS:VRCFF) stock the...

Pharmaceutical stocks have performed quite impressively in recent times and over the past few months; many new stocks have emerged that have garnered attention from investors. One of the pharmaceutical stocks to have emerged as a winner on Wednesday is that of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), which surged by as much as 9% on Wednesday on the back of major development with regards to one of its products.

A Major Development

Yesterday, it emerged that Aurinia Pharma’s New Drug Application for its product voclosporin, has been accepted by the United States Food and Drug Administration. It is a significant development for the company and the reaction from investors in Wednesday trading was understandable.

The product in question is meant for treating lupus nephritis, which is a critical inflammation of the patient’s kidneys brought about by the autoimmune disease systemic lupus erythematosus (SLE). However, more importantly, the FDA actually granted Aurinia a priority review in only 6 months. It is a major coup for the company since a priority review usually takes place in 10 months.

A PDUFA decision date for the same has been set by the agency for January 21 next year. In addition to that, the company was also informed by the FDA that at this time it is not planning to have an advisory committee meeting regarding the application.

The Chief Executive Officer of the company, Peter Greenleaf, stated that Aurinia is going to continue to collaborate with the agency during the course of the review process.

Concurrently, the company is going to work on its readiness for a commercial launch if the approval is granted by the FDA in the first fiscal quarter of 2021. Voclosporin is a potentially best in class treatment for the ailment in question and that is supported by data gleaned from across 2600 patients. The latest development could bring the stock in the radars of investors over the coming days. Sign up below for breakout alerts and updates on fast moving stocks.

Latest article

Alibaba Group Holding Limited (OTCMKTS:BABAF) Big Volume with Possible 60% Upside

Alibaba Group Holding Limited (OTCMKTS:  BABAF) is an over the counter stock traded on the OTC Pink markets in the Consumer Discretionary...

Trans Global Group Inc (OTCMKTS:TGGI) Stock In Focus After Operational Updates

The Trans Global Group Inc (OTCMKTS:TGGI) stock may not have been in the news today yet but it...

Why Hycroft Mining (NASDAQ:HYMC) Stock Shot Up 700%

If you are on the hunt for stocks that may have made major gains over the course of the past week, then...

Secure Paymentz releases banking software demo on Github

This is a paid announcement from one of our advertising partners. How to Leverage Your Trading Position by Secure...

Advanced Asset Management Announces New Website Launch

This is a paid announcement from one of our advertising partners. Financial Planner in Grandville, Michigan
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service